‘Remarkable’ Alzheimer drug reduces cognitive decline, results show

by

US drugmaker Eli Lilly on Wednesday announced its experimental Alzheimer’s drug significantly slowed cognitive and functional decline, results hailed as “remarkable” by experts.

Leave A Comment

Your email address will not be published. Required fields are marked *